Biocompatible nanohydroxyapatite rod technology for delivering molecular cargo to plants via foliar application, enabling transient production of plant-incorporated protectants like cinnamaldehyde for natural pest control in canola, soybean, and wheat crops.
This technology leverages nanohydroxyapatite (nHA) rods as biocompatible nanocarriers to deliver molecular cargo directly to plant cells through foliar (leaf-surface) application. The system enables plants to transiently produce their own pest-control compounds, such as cinnamaldehyde, offering a non-toxic alternative to conventional insecticides and fungicides. By using nanoparticles composed of naturally occurring calcium and phosphate minerals, this approach provides an environmentally friendly delivery platform for next-generation crop protection.
Core technology features:
Target applications:
The nanohydroxyapatite delivery platform has been validated in laboratory studies demonstrating successful conjugation with plasmids, partial protection of genetic cargo from nucleases, and confirmed in planta delivery across multiple plant species. Future validation efforts will focus on optimizing plasmid-nHA conjugates with trimethyl chitosan coatings, confirming nuclear delivery of tagged plasmids, transiently expressing cinnamaldehyde biosynthesis genes in canola, soybean, and wheat, and conducting effectiveness trials against thrips and other pests. The technology is currently at an early-to-mid stage of development, with demonstrated proof-of-concept delivery but requiring additional optimization and field validation before commercial deployment.
The University of South Dakota is a comprehensive public research university based in Vermillion with a statewide footprint through multiple campuses and professional programs. Industry collaboration is enabled by the USD Discovery District, a corporate–academic research park in Sioux Falls that offers flexible R&D space and adjacency to growing employers. The Sanford School of Medicine operates across regional sites and clinical departments embedded with major hospital systems, providing access to clinicians, patients and data for translational work. Research is supported by competitive federal funding and centralized sponsored-programs administration. A dedicated technology transfer office guides IP, licensing and startup formation to speed commercialization.